Cargando…
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
Late cardiac toxicity is a potentially lethal complication of cancer therapy, yet the pathogenic mechanism remains largely unknown, and few treatment options exist. Here we report DNA-damaging agents such as radiation and anthracycline chemotherapies inducing delayed cardiac inflammation following t...
Autores principales: | Shamseddine, Achraf, Patel, Suchit H., Chavez, Valery, Moore, Zachary R., Adnan, Mutayyaba, Di Bona, Melody, Li, Jun, Dang, Chau T., Ramanathan, Lakshmi V., Oeffinger, Kevin C., Liu, Jennifer E., Steingart, Richard M., Piersigilli, Alessandra, Socci, Nicholas D., Chan, Angel T., Yu, Anthony F., Bakhoum, Samuel F., Schmitt, Adam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767651/ https://www.ncbi.nlm.nih.gov/pubmed/36534085 http://dx.doi.org/10.1084/jem.20220809 |
Ejemplares similares
-
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
por: Yu, Anthony F., et al.
Publicado: (2020) -
Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression
por: Bakhoum, Mathieu F., et al.
Publicado: (2021) -
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
por: Yu, Anthony F., et al.
Publicado: (2023) -
Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology
por: Steingart, Richard M., et al.
Publicado: (2019) -
p53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino
por: Marney, Christina B., et al.
Publicado: (2021)